Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vitamin price-fixing settlement

This article was originally published in The Tan Sheet

Executive Summary

Jan. 15 hearing scheduled in D.C. federal court on fairness of proposed $50 mil. settlement by Merck KgaA and its affiliates of class action claims brought by direct purchasers of vitamins A, B, C, E, beta carotene, premixes. Judge Thomas Hogan preliminarily approved the settlement in September; opt-out deadline for companies who wish to exclude themselves is Dec. 9. Unlike earlier settlement involving seven defendants including Hoffman-LaRoche and BASF, Merck settlement amount is fixed and will not be reduced by the number of class members opting out. Remaining defendants in the class action, which is scheduled for trial March 12, include Sumitomo Chemical America, Tanabe USA, Lonza, Degussa-Huls, Reilly Industries, Nepera (1"The Tan Sheet" March 4, 2002, p. 11)...

You may also be interested in...

Vitamin price-fixing

Dietary supplement manufacturer and multi-level marketer Shaklee is one of eight representative plaintiffs in class action suit certified by D.C. federal Judge Thomas Hogan Feb. 25. Action was filed in June 2000 on behalf of direct purchasers of vitamins A, B, C, E, beta carotene and premixes from nonsettling defendants "or their co-conspirators" between Jan. 1, 1990 and Sept. 30, 1998. Defendants include Merck KgaA, Sumitomo Chemical America, Tanabe USA, Lonza, Nepera, Reilly Industries, Degussa-Huls. The thousands of class members will be given chance to opt out; 224 class members, representing approximately 75% of vitamin purchases at issue, previously opted out of a class settlement against seven defendants, including Hoffman-LaRoche, BASF (1"The Tan Sheet" April 3, 2000, p. 7)...

Coronavirus Pipeline: GSK And Clover Add To Collaborations

Companies continue to throw their hats into the ring against the virus, with strategies ranging from ‘off the shelf’ molecules to novel vaccine and anti-viral therapies

Switzerland And UK Work On Closer Medtech Ties As EU Links Fall Apart

Switzerland’s current economic and trading relationship with the UK is based on its MRA with the EU. So, where does this leave the two countries in trading with one another now each of their relationships with the EU are under threat?





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts